In previous blogs, we’ve examined the statistics behind Non-Compartmental PK/PD analysis. The existence of the Non-Compartmental Analysis (NCA) implies the existence of compartmental analysis, and, indeed, it is among... read more →
In our blog introducing bioequivalence, we described how studies establishing bioequivalence can be a way to avoid expensive clinical trials without compromising on the safety or efficacy of a... read more →
Bioassays can be expensive, both in terms of time and money. It is, therefore, sensible to consider bioassay optimisation: ways to design assays which minimise resource use while maximising... read more →
In parts 1 & 2 of our series on the confidence interval, we have covered some of the basic statistical concepts – means, standard deviations, and distributions –... read more →